Page last updated: 2024-08-26

paxilline and alendronate

paxilline has been researched along with alendronate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ikebuchi, Y; Kawagishi, R; Morishige, K; Murata, Y; Sawada, K; Tahara, M; Tasaka, K	1

Other Studies

1 other study(ies) available for paxilline and alendronate

Article	Year
Alendronate inhibits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of rho. Cancer research, 2002, Nov-01, Volume: 62, Issue:21 Topics: Alendronate; Cell Movement; Cell Survival; Cytoskeletal Proteins; Diterpenes; Drug Interactions; Enzyme Activation; Female; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Lysophospholipids; Myosin Light Chains; Ovarian Neoplasms; Paxillin; Phosphoproteins; Phosphorylation; Protein-Tyrosine Kinases; rho GTP-Binding Proteins; Tumor Cells, Cultured; Tyrosine	2002

Article

Year

Alendronate inhibits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of rho.

Cancer research, 2002, Nov-01, Volume: 62, Issue:21

Topics: Alendronate; Cell Movement; Cell Survival; Cytoskeletal Proteins; Diterpenes; Drug Interactions; Enzyme Activation; Female; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Lysophospholipids; Myosin Light Chains; Ovarian Neoplasms; Paxillin; Phosphoproteins; Phosphorylation; Protein-Tyrosine Kinases; rho GTP-Binding Proteins; Tumor Cells, Cultured; Tyrosine

2002